MXL has just delivered one of the most violent post-earnings re-ratings in recent semiconductor memory — a 78% single-day move last week that has left the stock trading well above where even its most bullish analyst sat until days ago.
The scale of the move frames everything else this week. MXL closed Tuesday at $81.68, up 57% on the week and more than 354% over the past month. The Q1 earnings release on April 23 triggered a 78% jump on day one and a further 109% gain over the following five sessions. That kind of velocity compresses the usual analytical framework: valuation multiples have been almost entirely repriced, and the analyst community is now playing catch-up from a standing start.
The most striking data point in analyst coverage is the gap between the stock price and the consensus target. Loop Capital's Ananda Baruah upgraded MXL from Hold to Buy on April 29, moving his target from $17 to $75 — still roughly 8% below where the stock already trades. Needham similarly upgraded to Buy the day after earnings, setting a $60 target. Stifel lifted its target from $34 to $49 while maintaining Buy. The consensus mean price target now stands at $51.60 — a third below the current price. That number is almost certainly stale in aggregate, compressed by analysts who haven't yet updated models, but the direction of travel is clear: the Street is chasing the stock upward after a move that blindsided even its bulls. EPS momentum ranks in the 98th percentile on a 30-day basis and the 90th percentile over 90 days, suggesting the earnings beat was not a one-quarter surprise but part of a building trend that the market had not fully credited.
The borrow market tells a quieter story than the price action might suggest. Short interest has eased to 6.1% of the free float, down roughly 6.6% over the past month as the stock climbed. Availability is wide: with a 52-week utilization peak of just 6.96% and current utilization around 3%, there is ample capacity to borrow relative to what is already shorted. Cost to borrow spiked sharply through late April — briefly reaching nearly 8% APR in the days around earnings — but has since collapsed back to 0.78%, effectively near-normal for a mid-cap semiconductor name. The short score of 39.6 is moderate and has barely moved over the past two weeks, suggesting that shorts are not rushing to add pressure after the move. With availability this loose, a short squeeze dynamic is not visible in the data.
Options positioning has shifted materially since earnings, but not to an extreme. The put/call ratio was running well below 0.20 during the weeks before earnings — the market was heavily skewed to calls — and has since climbed back to around 0.74, close to its 20-day mean of 0.47. The z-score is just 0.88, meaning option traders are modestly more defensive than recent habit but not alarmed. The 52-week high PCR of 2.12 is a long way off. The picture is of a market that loaded up on upside before the print, took profit as the move delivered, and is now rebalancing toward a more neutral posture.
Insider activity adds a cautionary note. Four board members — including independent directors Albert Moyer and Theodore Tewksbury — sold shares in the $76-$80 range between May 1 and May 5. Moyer's May 4 sale alone was worth approximately $1.2 million. These follow awards made on May 1, so the sales look partly mechanical, but the cluster is notable: multiple directors chose to sell almost immediately after receiving new equity grants, at prices they would not have anticipated weeks earlier. The net 90-day insider figure is nominally positive at roughly 268,000 shares, but that reflects award inflows rather than open-market buying. No insider has stepped in as a buyer at current levels.
The nearest US peer, SIMO, gained a more modest 2.8% on the week, while INTC — MXL's most correlated peer — dropped 29% over the same period. That divergence underlines how idiosyncratic this move was: it was driven by a company-specific catalyst, not a sector-wide re-rating, which means the stock lacks a peer benchmark to lean on as it consolidates.
What to watch next is the speed at which analyst targets catch up with the stock price — and whether any firm with a price target still meaningfully below $81 shifts the consensus enough to flip the ORTEX analyst_rec_diff factor, currently at the 100th percentile, into a less stretched reading. The next earnings event is pencilled in for July 22.
See the live data behind this article on ORTEX.
Open MXL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
